Bright Uro Receives Significant Funding for Urodynamics Innovation
Bright Uro, a forward-thinking medical device company dedicated to revolutionizing the care of lower urinary tract symptoms, has recently announced the receipt of a $1.75 million Translational Research Award. This funding comes from the Spinal Cord Injury Research Program (SCIRP), a component of the Department of Defense focused on advancing medical care for wounded veterans.
The Goals of the Glean Urodynamics System
The grant aims to enhance the Glean™ Urodynamics System, an innovative approach developed by Bright Uro for effective bladder management. This system seeks to provide critical insights into bladder pressure and volume, which is vital for patients managing neurogenic lower urinary tract dysfunction (nLUTD), a condition affecting a significant majority of spinal cord injury survivors.
Understanding Spinal Cord Injury in Veterans
Statistically, over 300,000 Americans live with spinal cord injuries, with combat injuries accounting for a considerable portion among veterans. The need for efficient urodynamics monitoring is emphasized by the statistic that around 80% of these individuals experience urinary complications shortly after their injury. The support provided through the SCIRP will assist in carrying forward Bright Uro's mission to alleviate these burdens.
Statement from the Leadership
Derek Herrera, the founder and CEO of Bright Uro, expressed pride in being recognized by SCIRP. As a retired Marine Raider who has experienced spinal cord injury firsthand, he understands the pressing need for effective urinary management solutions. He stated, "This funding validates our commitment to improving the quality of life for veterans. Bladder management is a daily challenge for many, and our Glean System could significantly alleviate that stress."
About Bright Uro
Located in Irvine, Bright Uro is dedicated to transforming traditional approaches to urodynamics. Their investigational Glean™ Urodynamics System aims to revolutionize bladder monitoring by providing a wireless and catheter-free solution, ultimately enhancing patient comfort and clinical outcomes. The efforts towards innovation not only aim at improving technical solutions but are also closely aligned with addressing the real-world needs of individuals living with LUTD.
Future Endeavors and Product Development
The funding from SCIRP will allow Bright Uro to further its research and product development efforts. By focusing on data-driven solutions, the Glean System is set to provide comprehensive support for patients and healthcare providers alike, helping streamline the management of bladder health.
Frequently Asked Questions
What is the Glean Urodynamics System?
The Glean Urodynamics System is a medical device designed for wireless and catheter-free urodynamics monitoring, aimed at improving bladder management for patients.
How much funding has Bright Uro received?
Bright Uro has been awarded a $1.75 million grant from the Spinal Cord Injury Research Program (SCIRP) to support their innovative projects.
What does the SCIRP do?
The SCIRP focuses on advancing medical treatment for spinal cord injuries, particularly benefiting veterans and enhancing their quality of life through improved healthcare solutions.
Who is the founder of Bright Uro?
Derek Herrera is the founder and CEO of Bright Uro, and he is a retired Marine Raider who experienced a spinal cord injury during combat.
What is Bright Uro's mission?
Bright Uro aims to transform care for lower urinary tract symptoms with innovative technology that disrupts outdated practices in urodynamics.
